RecruitingNCT04526093
Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)
MC-RWE : Real World Evidence in Patient-Reported Outcomes for Medical Cannabis: A Prospective Observational Study
Sponsor
University Health Network, Toronto
Enrollment
1,000 participants
Start Date
Jul 15, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.
Eligibility
Min Age: 19 Years
Inclusion Criteria3
- Subjects (≥19 years of age) who are MC-naïve or -experienced with a medical authorization for MC provided by a prescribing health care practitioner and who have provided informed consent
- Primary therapeutic indications for MC use: pain, epilepsy, sleep, and/or anxiety/depression.
- Subjects agree to use verified products and refrain from using any other cannabis products, either medical or recreational, during the duration of the study
Exclusion Criteria2
- Concomitant use of illicit drugs
- Concomitant use of recreational cannabis
Interventions
OTHERMedical Cannabis
Verified medical cannabis products available within the current real-world study conform to Health Canada testing requirements
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04526093
Related Trials
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT0679339767 locations
IMST for Dementia Risk Reduction
NCT073497061 location
Cerebellar Stimulation and Cognitive Control
NCT032171101 location
mHealth Intervention for Pain Self Management
NCT073323771 location
Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children
NCT074536151 location